Table of Contents page: Clinical Colorectal Cancer

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Select all

Download started.
Ok

Please select at least one article in order to proceed.

RAS Mutations as Predictive Biomarkers in Clinical Management of Metastatic Colorectal Cancer

Paul Waring,
Jeanne Tie,
Dipen Maru,
Christos S. Karapetis

Published online: November 11, 2015

p95-103

From Molecular Biology to Clinical Trials: Toward Personalized Colorectal Cancer Therapy

Sabina Palma,
Ariel O. Zwenger,
María V. Croce,
Martín C. Abba,
Ezequiel Lacunza

Published online: November 29, 2015

p104-115

The Prognostic Significance of the Hedgehog Signaling Pathway in Colorectal Cancer

Vassilis Papadopoulos,
Konstantinos Tsapakidis,
Natalia A. Riobo Del Galdo,
...
Nikos Sakellaridis,
Konstantinos Dimas,
Konstantinos Kamposioras

Published online: February 15, 2016

p116-127

Risk-Adapted Adjuvant Chemotherapy After Concomitant Fluoropyrimidine–Radiotherapy Neoadjuvant Treatment for Patients With Resectable CT3-4 or N+ Rectal Cancer: Five-Year Disease-Free Survival Results of a Single-Center Series

Javier Sastre,
Juan Jose Serrano,
Cristina Fernández,
...
Rosario Alfonso,
Sofía Córdoba,
Eduardo Díaz-Rubio

Published online: August 23, 2015

p128-134

Clinical Practice Patterns in Chemotherapeutic Treatment Regimens for Metastatic Colorectal Cancer

James McLean,
Young Soo Rho,
Gayathri Kuruba,
...
David Melnychuk,
Gerald Batist,
Petr Kavan

Published online: October 21, 2015

p135-140

Safety and Efficacy of Radioembolization in Elderly (≥ 70 Years) and Younger Patients With Unresectable Liver-Dominant Colorectal Cancer

Andrew S. Kennedy,
David S. Ball,
Steven J. Cohen,
...
Navesh K. Sharma,
Eric A. Wang
on behalf of the Metastatic Colorectal Cancer Liver Metastases Outcomes After Radioembolization (MORE) Study Investigators

Published online: September 30, 2015

p141-151.e6

Open Access

Intermediate Neoadjuvant Radiotherapy Combined With Total Mesorectal Excision for Locally Advanced Rectal Cancer: Outcomes After a Median Follow-Up of 5 Years

Lin Wang,
Yong-Heng Li,
Yong Cai,
Tian-Cheng Zhan,
Jin Gu

Published online: October 14, 2015

p152-157

Population-Based Cost-Minimization Analysis of CAPOX Versus Modified FOLFOX6 in the Adjuvant Treatment of Stage III Colon Cancer

Maria Y. Ho,
Albert Y. Chang,
Jenny Y. Ruan,
Winson Y. Cheung

Published online: September 29, 2015

p158-163

Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin

Stacey A. Cohen,
Chen Wu,
Ming Yu,
...
Konstantine T. Kalogeras,
George Fountzilas,
William M. Grady

Published online: November 11, 2015

p164-169

Therapy-Induced Cellular Senescence Induces Epithelial-to-Mesenchymal Transition and Increases Invasiveness in Rectal Cancer

Joana Tato-Costa,
Sandra Casimiro,
Teresa Pacheco,
...
Henrique Bicha Castelo,
João Ferreira,
Luís Costa

Published online: September 30, 2015

p170-178.e3

Reasons for Underuse of Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer

Jenny J. Ko,
Hagen F. Kennecke,
Howard J. Lim,
...
Ryan Woods,
Caroline Speers,
Winson Y. Cheung

Published online: September 29, 2015

p179-185

A Plasma-Based Protein Marker Panel for Colorectal Cancer Detection Identified by Multiplex Targeted Mass Spectrometry

Jeffrey J. Jones,
Bruce E. Wilcox,
Ryan W. Benz,
...
W. Daniel Hillis,
David B. Agus,
John E. Blume

Published online: March 24, 2016

p186-194.e13

Open Access

High-Grade Neuroendocrine Colorectal Carcinomas: A Retrospective Study of 100 Patients

Bruno Conte,
Ben George,
Michael Overman,
...
James C. Yao,
Scott Kopetz,
Arvind Dasari

Published online: December 28, 2015

e1-e7

Impact of Primary Tumor Site on Bevacizumab Efficacy in Metastatic Colorectal Cancer

Hui-li Wong,
Belinda Lee,
Kathryn Field,
...
Jayesh Desai,
Rachel Wong,
Peter Gibbs

Published online: February 12, 2016

e9-e15

Disease Control, Survival, and Toxicity Outcome After Intensified Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Single-Institution Experience

Francesca De Felice,
Daniela Musio,
Anna Lisa Magnante,
...
Ilaria Benevento,
Rossella Caiazzo,
Vincenzo Tombolini

Published online: February 12, 2016

e17-e22

Outcomes of Young Patients With Rectal Cancer From a Tertiary Cancer Care Centre in India

K.P. Haresh,
Rony Benson,
Supriya Mallick,
...
Rambha Pandey,
Pramod Kumar Julka,
Goura Kishor Rath

Published online: December 29, 2015

e23-e28

Effect of Application and Intensity of Bevacizumab-based Maintenance After Induction Chemotherapy With Bevacizumab for Metastatic Colorectal Cancer: A Meta-analysis

Alexander Stein,
Carsten Schwenke,
Gunnar Folprecht,
Dirk Arnold

Published online: December 17, 2015

e29-e39

Bevacizumab in Addition to Palliative Chemotherapy for Patients With Peritoneal Carcinomatosis of Colorectal Origin: A Nationwide Population-Based Study

Lieke G.E.M. Razenberg,
Yvette R.B.M. van Gestel,
Valery E.P.P. Lemmens,
Ignace H.J.T. de Hingh,
Geert-Jan Creemers

Published online: December 16, 2015

e41-e46

Adenocarcinoma of the Rectum—A Composite of Three Different Subtypes With Varying Outcomes?

Karthik Chandra Vallam,
Ashwin Desouza,
Munita Bal,
Prachi Patil,
Reena Engineer,
Avanish Saklani

Published online: December 16, 2015

e47-e52

Exclusion of Gastrointestinal Cancer Patients With Prior Cancer From Clinical Trials: Is This Justified?

Elizabeth C. Smyth,
Noelia Tarazona,
Clare Peckitt,
...
Sonia Mansukhani,
David Cunningham,
Ian Chau

Published online: November 27, 2015

e53-e59

Successful Completion of Adjuvant Chemotherapy in a Patient With Colon Cancer Experiencing 5-Fluorouracil–Induced Cardiac Vasospasm

Craig A. Vargo,
Marlo Blazer,
Joshua Reardon,
Martha Gulati,
Tanios Bekaii-Saab

Published online: November 10, 2015

e61-e63

Editorial Board

Published in issue: June 2016

A2-A5

June 2016

Reviews